How Denosumab (Prolia) Affects DEXA Bone Density: Timeline, Magnitude, and Monitoring
Denosumab (Prolia) increases DEXA-measured bone mineral density at the lumbar spine by 9.2% and total hip by 6.0% over 3 years. Learn the mechanism, expected gains by site, monitoring schedule, and what happens if you stop.
Read clinical review